SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-15-000051
Filing Date
2015-02-13
Accepted
2015-02-12 17:49:09
Documents
3
Period of Report
2015-02-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rgbp20150212form8k.htm 8-K 21015
2 EMPLOYMENT AGREEMENT BETWEEN CAVEN rgbp20150212form8kex10_1.htm EX-10.1 47977
3 EMPLOYMENT AGREEMENT BETWEEN KOOS rgbp20150212form8kex10_2.htm EX-10.2 51666
  Complete submission text file 0001607062-15-000051.txt   121841
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 15607902
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1